Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

4373 Elesclomol
6cf5457500d43b51bddf39ca2976039c7138ec90d3045d1258c979412a764734

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Properties

Chemistry

Elesclomol (INN, codenamed STA-4783) is a drug that triggers apoptosis (programmed cell death) in cancer cells. It is being developed by Synta Pharmaceuticals and GlaxoSmithKline as a chemotherapy adjuvant, and has received both fast track and orphan drug status from the U.S. Food and Drug Administration for the treatment of metastatic melanoma. Synta Pharmaceuticals announced on February 26, 2009 the suspension of all clinical trials involving Elesclomol due to safety concerns. In March 2010, Synta announced that the FDA had approved resuming clinical development of elesclomol, and that they expected to initiate one or more clinical trials for elesclomol in the second half of the year.

From Wikipedia, the free encyclopedia. License: CC BY-SA.
≪ Previous
4372 Next ≫
4374
Made with on Earth by F. Boffa and T. Calemme
This website does not track you.
Read the contract on Etherscan